Innovations such as long-acting formulations, digital monitoring platforms, telemedicine-based endocrine care, and supportive rare disease policies are accelerating global growth in the adrenal insufficiency treatment market. https://www.datamintelligence.com/research-report/heparin-induced-thrombocytopenia-market